1. WilliamWC，RobertSD，CharlesKS. A review of clinically relevant cardiac bio-chemical markers [J]. WisconsinMed J，2002，101：3.

2. Glatz JF，Storch J.Unravelling the significance of cellular fatty acid-binding proteins. Curr Opin Lipidol，2001，12:267-274.

3. McCann CJ，Glover BM，Menown IB. Novel biomarkers in early diagnosis of acute myocardial infarction compare with cardiac troponin T [J]. Eur Heart J，2008，29（230）：2843-2850.

4. Wu AH. Cardiac Markers. Znd ed. Totowa NJ USA：Humana Perss Inc.，2003：319- 338.

5. Figiel，Kasprzak JD，Peruga J，et al. Heart-type fatty acid-binding protein a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation [J]. Kardiol Pol，2008，166（3）：253-259.

6. Figiel，Kasprzak JD，Peruga J，et al. Heart-type fatty acid-binding protein a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation [J]. Kardiol Pol，2008，66（3）：253-259.

7. Chan CP，Sum KW，Cheung KY，et al. Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein[J]. Journal of Immunological Methods，2003，279：91-100.

8. Tanaka T. Sohmiya K，kitaura Y，et al. Clinical evaluation of point of care testing of heart-type fatty acid-binding （H-FABP）for the diagnosis of acute myocardial infarction[J].J Immunoassay Immunochem，2006，27（3）：225-238.

9. Aihashemi JA，Diagnostic accuracy of a beddide qualitative immunochromatographic test for acute myocardial infarction[J].Am J EmergMed，2006，24（2）:149-155.

10. Chan CP，Sanderson JE，Glatz JF，et al. A superior early myocardial infarction marder-human heart-type fatty acid-binding protein[J].Z Kardiol，2004，93:388-397.

11. Qzdemir M，Durakoglugil E，Gulbahar Q，et al. Heart-type fatty acid binding protein and myoglobin after reperfusion of acute myocardial infarction [J]. Acta Cardiol，2007，62（5）：473-478.

12. Nayashida N，Chihara S，Tayama E，et al.Influence of renal function on serum and urinary heart fatty acidbinding protein levels.）Cardiovasc Surg（Torino），2001，42（6）:735-740.

13. Tanaka T，Sohmiya K，et al.Clinical evaluation of point-of-care-testing of heart-type fatty acid-binding protein （H-FABP）for the diagnosis of acute myoc-ardial infarction. J Immunoassay Immunochem，2006，27（3）: 225-238.

14. Komaruma K，Sasaki T，et al. Heart-type fatty acid binding protein is a novel prog- nostic marker in patients with non-ischaemic dilated cardiomyopathy. Heart，2006 ， 92（5）：615-618.

15. Mauro Panteghini. Acute Coronary Syndrome Biochemical trategies in the Troponin Era. Chest，2002，122:1428-1435.

16. 高艳玲，葛志明，林宏扬，等.检测心脏型脂肪酸结合蛋白对判断慢性充血性心力衰竭严重程度的价值[J].新医学，2004，35（10）:597-599.

17. Ishii J，Ozaki Y，Lu J，et al. Prognostic value of serum concentration of heart type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome [J]. Clin Chem，2005，51（8）：1397-1404.

18. Niizeki T，Takeishi Y，Arimoto T，et al.Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure [J]. Circ J，2005，69 （10）：922-927.

19. Komamura K，Sasaki T，Hanatani A，et al. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischemic dilated cardiomyopathy [J]. Heart，2006，92（5）：615-618.

20. 李洁琪，李晓翔，吴立荣.心脏型脂肪酸结合蛋白在不稳定型心绞痛患者危险分层诊断中的价值[J].山东医药，2009，49（9）：1-2.

21. 朱红秋，朱平安，沈双宏.高敏C反应蛋白和心型脂肪酸结合蛋白对不稳定型心绞痛患者心脏事件的影响[J].中华心血管病杂志，2006，34（9）:808-811.

22. 刘敬东，范希文.病毒性心肌炎患儿心型脂肪酸结合蛋白的变化及意义[J].儿科药学杂志，2008，14（5）：17-18.

23. 顾坚，陈荣光，王大斌.心型脂肪酸结合蛋白及其他心肌标志物检测在病毒性心肌炎中的临床意义[J].临床儿科杂志，2008，26（5）：387-389.

24. 吴济强，岳红梅.阻塞性睡眠呼吸暂停低通气综合征患者血清心型脂肪酸结合蛋白和高敏C反应蛋白的变化及意义[J].临床荟萃，2009，24（16）:1402-1405.

25. Puls M，Dellas C，Lankeit M，et al.Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism[J]. Eur Heart J，2007，28（2）：224-229.